Interaction of tumor necrosis factor receptor-associated factor signaling proteins with the latent membrane protein 1 PXQXT motif is essential for induction of epidermal growth factor receptor expression

Molecular and Cellular Biology

Volumn 18, Issue 5, 1998, Pages 2835-2844

  Miller, William E ^a   Cheshire, Jeanette L ^a   Raab Traub, Nancy ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MEMBRANE PROTEIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; EPSTEIN BARR VIRUS; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0031953439     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.5.2835     Document Type: Article

References (67)

1. Baichwal, V. R., and B. Sugden. 1989. The multiple membrane-spanning segments of the BNLF-1 oncogene from Epstein-Barr virus are required for transformation. Oncogene 4:67-74.
2. b class I major histocompatibility gene. Mol. Cell. Biol. 7:305-313.
3. Baldwin, A. S., Jr., and P. A. Sharp. 1988. Two transcription factors, NF-kappa B and H2TF1, interact with a single regulatory sequence in the class I major histocompatibility complex promoter. Proc. Natl. Acad. Sci. USA 85:723-727.
4. Banchereau, J., P. de Paoli, A. Valle, E. Garcia, and F. Rousset. 1991. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science 251:70-72.
5. Berberich, I., G. Shu, and E. A. Clark. 1994. Cross-linking CD40 on B-cells rapidly activates nuclear factor-kB. J. Immunol. 153:4357-4366.
6. Brodeur, S. R., G. Cheng, D. Baltimore, and D. Thorley-Lawson. 1997. Localization of the major NF-κB-activating site and the sole TRAF3 binding site site of LMP1 defines two distinct signaling motifs. J. Biol. Chem. 272: 19777-19784.
7. Cheng, G., and D. Baltimore. 1996. TANK, a co-inducer with TRAF2 of TNF-and CD40L-mediated NF-κB activation. Genes Dev. 10:963-973.
8. Cheng, G., A. L. Cleary, Z.-S. Ye, D. I. Hong, S. Lederman, and D. Baltimore. 1995. Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science 267:1494-1498.
9. Cheshire, J. L., and A. S. Baldwin, Jr. 1997. Synergistic activation of NF-κB by tumor necrosis factor alpha and gamma interferon via enhanced IκBα degradation and de novo IκBβ degradation. Mol. Cell. Biol. 17:6746-6754.
10. Devergne, O., E. Hatzivassiliou, K. Izumi, K. Kaye, M. Kleijnen, E. Kieff, and G. Mosialos. 1996. TRAF1, TRAF2, and TRAF3 effect NF-κB activation by an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation. Mol. Cell. Biol. 16:7098-7108.
11. Eliopoulus, A. G., M. Stack, C. Dawson, K. Kaye, L. Hodgkin, S. Sihota, M. Rowe, and L. Young. 1997. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-κB pathway involving TNF receptor-associated factors. Oncogene 14:2899-2916.
12. Fahraeus, R., H. L. Fu, I. Ernberg, J. Finke, M. Rowe, G. Klein, K. Falk, E. Nilsson, M. Yadav, P. Busson, et al. 1988. Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int. J. Cancer. 42:329-338.
13. Fennewald, S., V. van Santen, and E. Kieff. 1984. The nucleotide sequence of a messenger RNA transcribed in latent growth transforming virus infection indicates that it may encode a membrane protein. J. Virol. 51:411-419.
14. Floettmann, J. E., and M. Rowe. 1997. Epstein-Barr virus latent membrane protein-1 (LMP1) C-terminus activation region 2 (CTAR2) maps to the far C-terminus and requires oligomerization for NF-κB activation. Oncogene 15:1851-1858.
15. Franken, M., O. Devergne, M. Rosenzweig, B. Annis, E. Kieff, and F. Wang. 1996. Comparative analysis identifies conserved tumor necrosis factor receptor-associated factor 3 binding sites in the human and simian Epstein-Barr virus oncogene LMP1. J. Virol. 70:7819-7826.
16. Fries, K. L., W. E. Miller, and N. Raab-Traub. 1996. Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene. J. Virol. 70:8653-8659.
17. Galibert, L., I. Durand, J. Banchereau, and F. Rousset. 1994. CD40-activated surface IgD-positive lymphocytes constitute the long term IL-4-dependent proliferating B cell pool. J. Immunol. 152:22-29.
18. Gedrich, R. W., M. C. Gilfillan, C. S. Duckett, J. L. Dongen, and C. B. Thompson. 1996. CD30 contains two binding sites with different specificities for members of the tumor necrosis factor-receptor-associated factor family of signal transducing proteins. J. Biol. Chem. 271:12852-12858.
19. Hammarskjold, M. L., and M. C. Simurda. 1992. Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-κB activity. J. Virol. 66:6496-6501.
20. Haskill, S., A. A. Beg, S. M. Tompkins, J. M. Morris, A. D. Yurochko, A. Sampson-Johanes, K. Mondal, P. Ralph, and A. S. Baldwin, Jr. 1991. Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity. Cell 65:1281-1289.
21. Hatzivassiliou, E., W. E. Miller, N. Raab-Traub, E. Kieff, and G. Mosialos. 1998. A fusion of the Epstein-Barr virus latent membrane protein 1 (LMP1) transmembrane domains to the CD40 cytoplasmic domain is similar to LMP1 in constitutive activation of epidermal growth factor expression, NF-κB, and stress activated protein kinase. J. Immunol. 160:1116-1121.
22. Henderson, S., M. Rowe, C. Gregory, D. Croom-Carter, F. Wang, R. Longnecker, E. Kieff, and A. Rickinson. 1991. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65:1107-1115.
23. Hennessy, K., S. Fennewald, M. Hummel, T. Cole, and E. Kieff. 1984. A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection. Proc. Natl. Acad. Sci. USA 81:7201-7211.
24. Hu, H. M., K. O'Rourke, M. S. Boguski, and V. M. Dixit. 1994. A novel RING finger protein interacts with the cytoplasmic domain of CD40. J. Biol. Chem. 269:30069-30072.
25. Huen, D. S., S. A. Henderson, S. Croom-Carter, and M. Rowe. 1995. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kB and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene 10:549-560.
26. Inui, S., T. Kaisho, H. Kikutani, I. Stamenkovic, B. Seed, E. Clark, and T. Kishimoto. 1990. Identification of the intracytoplasmic region essential for signal transduction through a B-cell activation molecule, CD40. Eur. J. Immunol. 20:1747-1753.
27. Ishida, T., S. Mizushima, S. Azuma, N. Kobayshi, T. Tojo, K. Suzuki, S. Aizawa, T. Watanabe, G. Mosialos, E. Kieff, T. Yamamoto, and J. Inoue. 1996. Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic domain. J. Biol. Chem. 271:28745-28748.
28. Ishida, T., T. Tojo, T. Aoki, N. Kobayashi, T. Ohishi, T. Watanabe, T. Yamamoto, and J. Inoue. 1996. TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediated CD40 signaling. Proc. Natl. Acad. Sci. USA 93:9437-9442.
29. Izumi, K., and E. Kieff. 1997. The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B-lymphocyte growth transformation and activate NF-κB. Proc. Natl. Acad. Sci. USA 94:12592-12597.
30. Izumi, K. M., K. M. Kaye, and E. D. Kieff. 1997. The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyts growth transformation. Proc. Natl. Acad. Sci. USA 94:1447-1452.
31. Kaye, K., O. Devergne, J. Harada, K. Izumi, R. Yalamanchili, E. Kieff, and G. Mosialos. 1996. Tumor necrosis receptor associated factor 2 is a mediator of NF-kB activation by latent infection membrane protein 1. the Epstein-Barr virus transforming protein. Proc. Natl. Acad. Sci. USA 93:11085-11090.
32. Kaye, K. M., K. M. Izumi, and E. Kieff. 1993. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl. Acad. Sci. USA 90:9150-9154.
33. Kieff, E. 1996. Epstein-Barr virus and its replication, p. 2343-2396. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Virology, 3rd ed. Lippinscott-Raven Publishers, Philadelphia, Pa.
34. Kieser, A., E. Kilger, O. Gires, M. Ueffing, W. Kolch, and W. Hammerschmidt. 1997. Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade. EMBO J. 16:6478-6485.
35. Laherty, C. D., H. M. Hu, A. W. Opipari, F. Wang, and V. M. Dixit. 1992. The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating NF-κB. J. Biol. Chem. 267:24157-24160.
36. Liebowitz, D., and E. Kieff. 1989. Epstein-Barr virus latent membrane protein: induction of B-cell activation antigens and membrane patch formation does not require vimentin. J. Virol. 63:4051-4054.
37. Liebowitz, D., J. Mannick, K. Takada, and E. Kieff. 1992. Phenotypes of Epstein-Barr virus LMP1 deletion mutants indicate transmembrane and amino-terminal cytoplasmic domains necessary for effects in B-lymphoma cells. J. Virol. 66:4612-4616.
38. Miller, W. E., J. L. Cheshire, A. S. Baldwin, Jr., and N. Raab-Traub. The NPC derived C15 LMP1 protein confers enhanced activation of NF-κB and induction of the EGFR in epithelial cells. Oncogene, in press.
39. Miller, W. E., H. S. Earp, and N. Raab-Traub. 1995. The Epstein-Barr virus latent membrane protein1 induces expression of the epidermal growth factor receptor. J. Virol. 69:4390-4398.
40. Miller, W. E., G. Mosialos, E. Kieff, and N. Raab-Traub. 1997. Epstein-Barr virus LMP1 induction of the EGFR is mediated through a TRAF signaling pathway distinct from NF-κB activation. J. Virol. 71:586-594.
41. Min, W., and J. Pober. 1997. TNF initiates E-selectin transcription in human endothelial cells through parallel TRAF-NF-kB and TRAF-RAC/CDC42-JNK-c-Jun/ATF-2 pathways. J. Immunol. 159:3508-3518.
42. Mitchell, T., and B. Sugden. 1995. Stimulation of NF-κB-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus. J. Virol. 69:2968-2976.
43. Moorthy, R. K., and D. A. Thorley-Lawson. 1993. All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts. J. Virol. 67:1638-1646.
44. Mosialos, G., M. Birkenbach, R. Yalamanchili, T. VanArsdale, C. Ware, and E. Kieff. 1995. The Epstein-Barr virus transforming protein LMP1 engages signalling proteins for the tumor necrosis factor receptor family. Cell 80: 389-399.
45. Paine, E., R. I. Scheinman, A. S. Baldwin, Jr., and N. Raab-Traub. 1995. Expression of LMP1 in epithelial cells leads to the activation of a select subset of NF-κB/Rel family proteins. J. Virol. 69:4572-4576.
46. Rajadurai, P., U. Prasad, R. Sadler, K. Flynn, and N. Raab-Traub. 1995. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N. Engl. J. Med. 333:693-698.
47. Rickinson, A. B., and E. Kieff. 1996. Epstein-Barr virus, p. 2397-2446. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.). Virology, 3rd ed. Lippinscott-Raven Publishers, Philadelphia, Pa.
48. Rothe, M., V. Sarma, V. M. Dixit, and D. V. Goeddel. 1995. TRAF-2 mediated activation of NF-κB by TNF receptor 2 and CD40. Science 269:1424-1427.
49. Rothe, M., S. C. Wong, W. J. Henzel, and D. V. Goeddel. 1994. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78:681-692.
50. Saeland, S., V. Duvert, I. Moreau, and J. Banchereau. 1993. Human B cell precursors proliferate and express CD23 after CD40 ligation. J. Exp. Med. 178:113-120.
51. Sandberg, M., W. Hammerschmidt, and B. Sugden. 1997. Characterization of LMP1's association with TRAF1, TRAF2, and TRAF3. J. Virol. 71:4649-4656.
52. Sarma, V., Z. Lin, L. Clark, B. M. Rust, M. Tewari, R. J. Noelle, and V. M. Dixit. 1995. Activation of the B-cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis. J. Biol. Chem. 270:12343-12346.
53. Sato, T., S. Irie, and J. C. Reed. 1995. A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40. FEBS Lett. 358:113-118.
54. Scheinman, R. I., A. A. Begg, and A. S. Baldwin, Jr. 1993. NF-κB p100 (Lyt-10) is a component of H2TF1 and can function as an IκB-like molecule. Mol. Cell. Biol. 13:6089-6101.
55. Scherer, D. C., J. A. Brockman, Z. Chen, T. Maniatis, and D. Ballard. 1995. Signal-induced degradation of IκBα requires site-specific ubiquitination. Proc. Natl. Acad. Sci. USA 92:11259-11263.
56. Smith, C., T. Farrah, and R. Goodwin. 1994. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76: 959-962.
57. Takeuchi, M., M. Rothe, and D. V. Goeddel. 1996. Anatomy of TRAF2. J. Biol. Chem. 271:19935-19942.
58. Tartaglia, L. V., and D. V. Goeddel. 1992. Two TNF receptors. Immunol. Today 13:151-153.
59. Vandenabeele, P., W. Declercq, R. Beyaert, and W. Fiers. 1995. Two tumour necrosis factor receptors: structure and function. Trends Cell Biol. 5:392-399.
60. Wang, D., D. Liebowitz, and E. Kieff. 1985. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831-840.
61. Wang, D., D. Liebowitz, and E. Kieff. 1988. The truncated form of the Epstein-Barr virus latent-infection membrane protein expressed in virus replication does not transform rodent fibroblasts. J. Virol. 62:2337-2346.
62. Wang, D., D. Liebowitz, F. Wang, C. Gregory, A. Rickinson, R. Larson, T. Springer, and E. Kieff. 1988. Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity. J. Virol. 62:4173-4184.
63. Wang, F., C. Gregory, C. Sample, M. Rowe, D. Liebowitz, R. Murray, A. Rickinson, and E. Kieff. 1990. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J. Virol. 64:2309-2318.
64. Wang, S., M. Rowe, and E. Lundgren. 1996. Expression of the Epstein-Barr virus transforming protein LMP1 causes a rapid and transient stimulation of the bcl-2 homologue Mcl-1 levels in B-cell lines. Cancer Res. 56:4610-4613.
65. Xu, Y., G. Cheng, and D. Baltimore. 1996. Targeted disruption of TRAF3 leads to postnatal lethality and defective T-lymphocyte immune responses. Immunity 5:407-415.
66. Young, L., C. Alfieri, K. Hennessy, H. Evans, C. OHara, K. C. Anderson, J. Ritz, R. S. Shapiro, A. Rickinson, E. Kieff, and J. I. Cohen. 1989. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N. Engl. J. Med. 321:1080-1085.
67. Young, L., C. Dawson, D. Clark, H. Rupani, P. Busson, T. Tursz, A. Johnson, and A. Rickinson. 1988. Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J. Gen. Virol. 69:1051-1065.